106 related articles for article (PubMed ID: 29786798)
21. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
[TBL] [Abstract][Full Text] [Related]
22. Functional Studies on Steroid Receptors.
Schlanger S; Heemers HV
Methods Mol Biol; 2018; 1786():117-130. PubMed ID: 29786790
[TBL] [Abstract][Full Text] [Related]
23. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL
Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968
[TBL] [Abstract][Full Text] [Related]
24. Androgen regulation of gene expression.
Lamont KR; Tindall DJ
Adv Cancer Res; 2010; 107():137-62. PubMed ID: 20399963
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70.
Peng Y; Li CX; Chen F; Wang Z; Ligr M; Melamed J; Wei J; Gerald W; Pagano M; Garabedian MJ; Lee P
Am J Pathol; 2008 Jan; 172(1):225-35. PubMed ID: 18156210
[TBL] [Abstract][Full Text] [Related]
26. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
27. ING3 promotes prostate cancer growth by activating the androgen receptor.
Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
[TBL] [Abstract][Full Text] [Related]
28. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
29. PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion.
Zhang Z; Jin B; Jin Y; Huang S; Niu X; Mao Z; Xin D
Exp Cell Res; 2017 Jan; 350(1):1-8. PubMed ID: 27756608
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C
J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740
[TBL] [Abstract][Full Text] [Related]
31. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.
Miyajima N; Maruyama S; Bohgaki M; Kano S; Shigemura M; Shinohara N; Nonomura K; Hatakeyama S
Cancer Res; 2008 May; 68(9):3486-94. PubMed ID: 18451177
[TBL] [Abstract][Full Text] [Related]
32. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
[TBL] [Abstract][Full Text] [Related]
33. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
34. RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells.
Dayal S; Zhou J; Manivannan P; Siddiqui MA; Ahmad OF; Clark M; Awadia S; Garcia-Mata R; Shemshedini L; Malathi K
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257035
[TBL] [Abstract][Full Text] [Related]
35. Molecular aspects of androgenic signaling and possible targets for therapeutic intervention in prostate cancer.
Culig Z; Santer FR
Steroids; 2013 Sep; 78(9):851-9. PubMed ID: 23643785
[TBL] [Abstract][Full Text] [Related]
36. Expression and function of androgen receptor in carcinoma of the prostate.
Culig Z; Hobisch A; Bartsch G; Klocker H
Microsc Res Tech; 2000 Dec; 51(5):447-55. PubMed ID: 11074615
[TBL] [Abstract][Full Text] [Related]
37. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of steroid receptor expression in the human prostate carcinoma cell line 22RV1 and quantification of androgen effects on mRNA regulation of prostate-specific genes.
Hartel A; Didier A; Ulbrich SE; Wierer M; Meyer HH
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):187-97. PubMed ID: 15555912
[TBL] [Abstract][Full Text] [Related]
39. KIBRA promotes prostate cancer cell proliferation and motility.
Stauffer S; Chen X; Zhang L; Chen Y; Dong J
FEBS J; 2016 May; 283(10):1800-11. PubMed ID: 27220053
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor corepressors and prostate cancer.
Burd CJ; Morey LM; Knudsen KE
Endocr Relat Cancer; 2006 Dec; 13(4):979-94. PubMed ID: 17158750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
